Higher non-HDL-cholesterol to HDL-cholesterol ratio is linked to increase in non-alcoholic fatty liver disease: secondary analysis based on a longitudinal study

被引:1
|
作者
Gao, Shengqiang [1 ]
Ramen, Kuvaneshan [2 ]
Yu, Shian [1 ]
Luo, Jiansheng [1 ]
机构
[1] Zhejiang Univ, Affiliated Jinhua Hosp, Sch Med, Dept Hepatobiliary & Pancreat Surg, Jinhua 321000, Zhejiang, Peoples R China
[2] Dept Hepatobiliary & Pancreat Surg, Vacoas Phoenix, Mauritius
关键词
Non-HDLc/HDLc ratio; prospective study; fatty liver disease; NAFLD; STEATOHEPATITIS; POPULATION; PREVALENCE;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Non-high-density lipoprotein cholesterol (non-HDLc) to HDLc ratio (non-HDLc/HDLc), is a viable predictor of metabolic syndrome, insulin resistance, and other cardiac diseases. The study aimed to assess whether non-HDLC/HDLc ratio is an independent predictor of NAFLD. Methods: The present study was a longitudinal study, involving 16173 Chinese men and women, aging 14-95 years old, who received a medical check-up program in a health examination Center in China. A total of 16173 initially NAFLD-free non-obese individuals were included, who completed a 5-year follow-up examination in the longitudinal study. NAFLD was defined by ultrasonographic detection of steatosis in the absence of other liver disease. Univariate and multivariate Cox proportional hazards analyses were used to assess the association between nonHDLC/HDLc and NAFLD. ROC curve analysis was performed to compare the predictive value between the nonHDLc/HDLc and the nonHDLc for NAFLD. Results: During the five-year follow-up period, a total of 2322 participants (14.4%) developed NAFLD. The HRs for NAFLD in the longitudinal population were 1.3 (95% CI 1.1 to 1.7) and 1.5 (95% CI 1.1 to 2.0) compared with Q1. AUC values for nonHDLc/HDLc ratios (0.705) were significantly higher than nonHDLc (0.656) (P<0.05), while the cut-off value for the detection of NAFLD was 2.26. Individuals with higher nonHDLc/HDLc ratio had an increased cumulative incidence rate of NAFLD in non-obese individuals. Conclusion: The Non-HDLc ratio/HDLc is an independent predictor of NAFLD. This may help with early identification of high-risk individuals.
引用
收藏
页码:2569 / 2575
页数:7
相关论文
共 50 条
  • [21] ApoB/ApoA1 ratio and non-HDL-cholesterol/HDL-cholesterol ratio are associated to metabolic syndrome in patients with type 2 diabetes mellitus subjects and to ischemic cardiomyopathy in diabetic women
    Lizet Reynoso-Villalpando, Gabriela
    Sevillano-Collantes, Cristina
    Valle, Yeminia
    Moreno-Ruiz, Inmaculada
    Ramon Padilla-Gutierrez, Jorge
    Javier del Canizo-Gomez, Francisco
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2019, 66 (08): : 502 - 511
  • [22] LDL:HDL Ratio as a Risk Factor for Non-Alcoholic Steatohepatitis (NASH) in Non-Obese Non-Alcoholic Fatty Liver Disease (NAFLD) Patients
    Mitchell, Brittany
    Aggarwal, Manik
    McCullough, Arthur
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S544 - S545
  • [23] ATHEROGENIC DYSLIPIDEMIA AND INFLAMMATION IN HIRSUTISM: NON-HDL CHOLESTEROL AND NON-HDL TO HDL RATIO ARE HIGHER IN WOMEN WITH HIRSUTISM
    Deniz, Avci
    Atil, Avci
    Cetinkaya, Ali
    Selahattin, Erdem
    Hatice, Karakose Dogan
    Ertas, Ragip
    Kemal, Ozyurt
    ACTA MEDICA MEDITERRANEA, 2019, 35 (02): : 1109 - 1114
  • [24] The Effect of Three Mediterranean Diets on Remnant Cholesterol and Non-Alcoholic Fatty Liver Disease: A Secondary Analysis
    Campanella, Angelo
    Iacovazzi, Palma A.
    Misciagna, Giovanni
    Bonfiglio, Caterina
    Mirizzi, Antonella
    Franco, Isabella
    Bianco, Antonella
    Sorino, Paolo
    Caruso, Maria G.
    Cisternino, Anna M.
    Buongiorno, Claudia
    Liuzzi, Rosalba
    Osella, Alberto R.
    NUTRIENTS, 2020, 12 (06) : 1 - 16
  • [25] Non-HDL cholesterol and LDL cholesterol in the dyslipidemic classification in patients with nonalcoholic fatty liver disease
    Tingting Du
    Xingxing Sun
    Xuefeng Yu
    Lipids in Health and Disease, 16
  • [26] Non-HDL cholesterol and LDL cholesterol in the dyslipidemic classification in patients with nonalcoholic fatty liver disease
    Du, Tingting
    Sun, Xingxing
    Yu, Xuefeng
    LIPIDS IN HEALTH AND DISEASE, 2017, 16
  • [27] IMPAIRED HDL CHOLESTEROL EFFLUX CAPACITY IN SUBJECTS WITH METABOLICALLY-BUT NOT GENETICALLY-DRIVEN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Di Costanzo, A.
    Ronca, A.
    D'Erasmo, L.
    Manfredini, M.
    Baratta, F.
    Pastori, D.
    Polito, L.
    Di Martino, M.
    Angelico, F.
    Del Ben, M.
    Favari, E.
    Arca, M.
    ATHEROSCLEROSIS, 2020, 315 : E154 - E155
  • [28] Recent insights on the role of cholesterol in non-alcoholic fatty liver disease
    Arguello, Graciela
    Balboa, Elisa
    Arrese, Marco
    Zanlungo, Silvana
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2015, 1852 (09): : 1765 - 1778
  • [29] Impaired HDL cholesterol efflux capacity in people with type 1 diabetes and non-alcoholic fatty liver disease (prospective InLipoDiab1 Study)
    Grzelka-Wozniak, A.
    Uruska, A.
    Rohatgi, A.
    Saldanha, S.
    Flotynska, J.
    Cieluch, A.
    Kaczmarek, A.
    Pypec, A.
    Zozulinska-Ziolkiewicz, D.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S507 - S508
  • [30] Apolipoprotein B and non-HDL-cholesterol assessments in different at risk categories: A community based analysis
    Hoag, G.
    Dias, V.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 117 - 117